-
公开(公告)号:US11193115B2
公开(公告)日:2021-12-07
申请号:US17200110
申请日:2021-03-12
Applicant: Inscripta, Inc.
Inventor: Benjamin Mijts , Juhan Kim , Aamir Mir , Andrew Garst , Kyle Seamon
IPC: C12N9/22 , C12N15/113
Abstract: The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
-
92.
公开(公告)号:US20210355467A1
公开(公告)日:2021-11-18
申请号:US17388358
申请日:2021-07-29
Applicant: Inscripta, Inc.
Inventor: Aamir Mir , Andrew Garst , Stephen Federowicz , Kyle Seamon
Abstract: The present disclosure relates to methods and compositions that allow one to identify in vivo edited cells when employing nucleic-acid guided editing. Additionally provided are automated multi-module instruments for performing editing and selection methods and using the compositions.
-
公开(公告)号:US20210324355A1
公开(公告)日:2021-10-21
申请号:US17200110
申请日:2021-03-12
Applicant: Inscripta, Inc.
Inventor: Benjamin Mijts , Juhan Kim , Aamir Mir , Andrew Garst , Kyle Seamon
IPC: C12N9/22 , C12N15/113
Abstract: The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
-
公开(公告)号:US20210301270A1
公开(公告)日:2021-09-30
申请号:US17200089
申请日:2021-03-12
Applicant: Inscripta, Inc.
Inventor: Benjamin Mijts , Juhan Kim , Aamir Mir , Andrew Garst , Kyle Seamon
IPC: C12N9/22 , C12N15/113
Abstract: The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
-
公开(公告)号:US20210214672A1
公开(公告)日:2021-07-15
申请号:US17140059
申请日:2021-01-02
Applicant: Inscripta, Inc.
Inventor: Aamir Mir , Erik Zimmerman , Emily Feldman , Benjamin Mijts , Andrew Garst
Abstract: The present disclosure provides compositions, automated multi-module instruments and methods to increase the percentage of edited mammalian cells in a cell population when employing nucleic-acid guided editing.
-
公开(公告)号:US20210171923A1
公开(公告)日:2021-06-10
申请号:US17084522
申请日:2020-10-29
Applicant: Inscripta, Inc.
Inventor: Benjamin Mijts , Juhan Kim , Aamir Mir , Andrew Garst , Kyle Seamon
IPC: C12N9/22 , C12N15/113
Abstract: The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
-
97.
公开(公告)号:US20210095241A1
公开(公告)日:2021-04-01
申请号:US17101897
申请日:2020-11-23
Applicant: Inscripta, Inc.
Inventor: Phillip Belgrader , Don Masquelier , Andrew Garst , Richard Fox
Abstract: The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.
-
公开(公告)号:US10883095B1
公开(公告)日:2021-01-05
申请号:US16837212
申请日:2020-04-01
Applicant: Inscripta, Inc.
Inventor: Benjamin Mijts , Juhan Kim , Aamir Mir , Andrew Garst , Kyle Seamon
IPC: C12N9/22 , C12N15/113
Abstract: The present disclosure provides new RNA-guided nucleases for making rational, direct edits to nucleic acids in live cells.
-
99.
公开(公告)号:US10851339B1
公开(公告)日:2020-12-01
申请号:US17013360
申请日:2020-09-04
Applicant: Inscripta, Inc.
Inventor: Phillip Belgrader , Don Masquelier , Andrew Garst , Richard Fox
Abstract: The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.
-
100.
公开(公告)号:US10752874B2
公开(公告)日:2020-08-25
申请号:US16686066
申请日:2019-11-15
Applicant: Inscripta, Inc.
Inventor: Charles Johnson , Miles Gander , Don Masquelier , Phillip Belgrader , Andrew Garst , Matthew Estes , Bruce Chabansky , Jorge Bernate
IPC: C12M1/00 , C12M1/26 , C12M3/00 , C12N15/87 , B01D25/00 , B01D63/08 , B01D29/05 , B01D71/02 , B01D69/06
Abstract: The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.
-
-
-
-
-
-
-
-
-